Mark Theeuwes

Mark Theeuwes has a strong background in the pharmaceutical industry, with experience in various senior roles. Mark'smost recent position is as a Member of the Board of Directors for the Epilepsy Foundation starting in 2022. Prior to that, they served as the President and Chief Executive Officer of Receptor Life Sciences, Inc. since 2021.

Before their role at Receptor Life Sciences, Inc., Mark held the position of Principal at Pharmaceutical Services, LLC starting in 2018. From 2019 to 2020, they served as the Chief Operating Officer at Engage Therapeutics and from 2018 to 2019, they held the position of Vice President, External Operations at Engage Therapeutics.

Mark also has a wealth of experience from their previous roles. Mark served as the Vice President of Sales, Trade Relations, and Commercial Operations at Egalet Corporation from 2016 to 2018, and as the Vice President of Analytics from 2015 to 2016. Mark was also the Executive Director of Business Information and Decision Support at NPS Pharmaceuticals from 2014 to 2015.

Additionally, Mark held leadership positions at ViroPharma Incorporated, OraPharma Inc., and OraPharma. Mark was the Director of Commercial Operations at ViroPharma Incorporated from 2012 to 2014, the Director of Commercial Analytics and Operations at OraPharma Inc. from 2011 to 2012, and the Senior Manager of Sales Force Effectiveness at OraPharma from 2009 to 2011.

At Johnson & Johnson, Mark held various managerial positions, including Manager of Strategic Analytics from 2009 to 2009, Region Analytics Manager from 2007 to 2009, and District Manager at PriCara from 2003 to 2007.

Overall, Mark Theeuwes brings extensive experience and expertise in the pharmaceutical industry, particularly in sales, analytics, and operations.

Mark Theeuwes completed a Bachelor of Science degree in Biochemistry from the University of California, Riverside, from 1994 to 1997. Mark also obtained a Certified Medical Representative (CMR) degree in Business in Healthcare from 2005 to 2006.